-transparent.png){kind=logo}
The Ames test on indicator bacteria S. typhimurium TA 1950 and TA 100 and the differential spectrophotometry have shown that cytochrome P-450-dependent monooxygenases of mammalian liver participate in the metabolism of antitumour drugs (cyclophosphamide, thiophosphamide) and of nitrosomorpholine (promutagen). Data concerning prospidin indicate that microsomal liver enzymes either induce no metabolic transformations of this preparation or the formed metabolites possess the mutagenic activity similar to that of the parent compound.
Related Publications
N G Oblapenko, and
A Z Prikhod'ko, and
L M Fonshteĭn, and
V A Chernov
September 1986,
Genetika,
N G Oblapenko, and
A Z Prikhod'ko, and
L M Fonshteĭn, and
V A Chernov
May 1971,
Saishin igaku. Modern medicine,
N G Oblapenko, and
A Z Prikhod'ko, and
L M Fonshteĭn, and
V A Chernov
July 1978,
Bollettino chimico farmaceutico,
N G Oblapenko, and
A Z Prikhod'ko, and
L M Fonshteĭn, and
V A Chernov
January 1989,
Bulletin du cancer,
N G Oblapenko, and
A Z Prikhod'ko, and
L M Fonshteĭn, and
V A Chernov
March 2015,
Advanced pharmaceutical bulletin,
N G Oblapenko, and
A Z Prikhod'ko, and
L M Fonshteĭn, and
V A Chernov
April 1985,
American journal of hospital pharmacy,
N G Oblapenko, and
A Z Prikhod'ko, and
L M Fonshteĭn, and
V A Chernov
September 1971,
Bollettino della Societa italiana di biologia sperimentale,
N G Oblapenko, and
A Z Prikhod'ko, and
L M Fonshteĭn, and
V A Chernov
February 1961,
Praxis,
N G Oblapenko, and
A Z Prikhod'ko, and
L M Fonshteĭn, and
V A Chernov
June 1963,
Sheng li xue bao : [Acta physiologica Sinica],
N G Oblapenko, and
A Z Prikhod'ko, and
L M Fonshteĭn, and
V A Chernov
June 1963,
[Chiryo] [Therapy],
